Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
2.700
+0.020 (0.75%)
Feb 21, 2025, 4:00 PM EST - Market closed
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $58.50 million as of February 21, 2025. Its market cap has increased by 196.94% in one year.
Market Cap
58.50M
Enterprise Value
40.85M
1-Year Change
196.94%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $58.50M, a decrease of -63.19%. That is a compound annual growth rate of -12.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 58.50M | 17.47% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |